The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.
Carmena, R
The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. [electronic resource] - Metabolism: clinical and experimental Jul 1993 - 895-901 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0026-0495
10.1016/0026-0495(93)90066-w doi
Adult
Apolipoproteins E--genetics
Female
Heterozygote
Humans
Hyperlipoproteinemia Type II--blood
Lipids--blood
Lovastatin--therapeutic use
Male
Middle Aged
Phenotype
Polymorphism, Genetic
Receptors, LDL--genetics
Retrospective Studies
The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. [electronic resource] - Metabolism: clinical and experimental Jul 1993 - 895-901 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0026-0495
10.1016/0026-0495(93)90066-w doi
Adult
Apolipoproteins E--genetics
Female
Heterozygote
Humans
Hyperlipoproteinemia Type II--blood
Lipids--blood
Lovastatin--therapeutic use
Male
Middle Aged
Phenotype
Polymorphism, Genetic
Receptors, LDL--genetics
Retrospective Studies